United States Nonalcoholic Fatty Liver Disease Market Report 2016

September 2016 | 115 pages | ID: UD5202943A9EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nonalcoholic Fatty Liver Disease

Revenue, means the sales value of Nonalcoholic Fatty Liver Disease

This report studies sales (consumption) of Nonalcoholic Fatty Liver Disease in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Conatus Pharmaceuticals
• Daewoong Pharmaceutical
• Galmed International
• Kyorin Pharmaceutical
• Metabolic Solutions Development
• Novartis AG
• Phenex Pharmaceuticals
• Raptor Pharmaceuticals
• TCM Biotech International
• Tobira Therapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Nonalcoholic Fatty Liver Disease in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Nonalcoholic Fatty Liver Disease Market Report 2016

1 NONALCOHOLIC FATTY LIVER DISEASE OVERVIEW

1.1 Product Overview and Scope of Nonalcoholic Fatty Liver Disease
1.2 Classification of Nonalcoholic Fatty Liver Disease
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Nonalcoholic Fatty Liver Disease
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Nonalcoholic Fatty Liver Disease (2011-2021)
  1.4.1 United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
  1.4.2 United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)

2 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE COMPETITION BY MANUFACTURERS

2.1 United States Nonalcoholic Fatty Liver Disease Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Nonalcoholic Fatty Liver Disease Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Nonalcoholic Fatty Liver Disease Average Price by Manufactures (2015 and 2016)
2.4 Nonalcoholic Fatty Liver Disease Market Competitive Situation and Trends
  2.4.1 Nonalcoholic Fatty Liver Disease Market Concentration Rate
  2.4.2 Nonalcoholic Fatty Liver Disease Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Type (2011-2016)
3.2 United States Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
3.3 United States Nonalcoholic Fatty Liver Disease Price by Type (2011-2016)
3.4 United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)

4 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Nonalcoholic Fatty Liver Disease Sales and Market Share by Application (2011-2016)
4.2 United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURERS PROFILES/ANALYSIS

5.1 Conatus Pharmaceuticals
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Daewoong Pharmaceutical
  5.2.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Galmed International
  5.3.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Kyorin Pharmaceutical
  5.4.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Metabolic Solutions Development
  5.5.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Novartis AG
  5.6.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Phenex Pharmaceuticals
  5.7.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Raptor Pharmaceuticals
  5.8.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 TCM Biotech International
  5.9.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Tobira Therapeutics
  5.10.2 Nonalcoholic Fatty Liver Disease Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 NONALCOHOLIC FATTY LIVER DISEASE MANUFACTURING COST ANALYSIS

6.1 Nonalcoholic Fatty Liver Disease Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES NONALCOHOLIC FATTY LIVER DISEASE MARKET FORECAST (2016-2021)

10.1 United States Nonalcoholic Fatty Liver Disease Sales, Revenue Forecast (2016-2021)
10.2 United States Nonalcoholic Fatty Liver Disease Sales Forecast by Type (2016-2021)
10.3 United States Nonalcoholic Fatty Liver Disease Sales Forecast by Application (2016-2021)
10.4 Nonalcoholic Fatty Liver Disease Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nonalcoholic Fatty Liver Disease
Table Classification of Nonalcoholic Fatty Liver Disease
Figure United States Sales Market Share of Nonalcoholic Fatty Liver Disease by Type in 2015
Table Application of Nonalcoholic Fatty Liver Disease
Figure United States Sales Market Share of Nonalcoholic Fatty Liver Disease by Application in 2015
Figure United States Nonalcoholic Fatty Liver Disease Sales and Growth Rate (2011-2021)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate (2011-2021)
Table United States Nonalcoholic Fatty Liver Disease Sales of Key Manufacturers (2015 and 2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Figure 2016 Nonalcoholic Fatty Liver Disease Sales Share by Manufacturers
Table United States Nonalcoholic Fatty Liver Disease Revenue by Manufacturers (2015 and 2016)
Table United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table 2016 United States Nonalcoholic Fatty Liver Disease Revenue Share by Manufacturers
Table United States Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Nonalcoholic Fatty Liver Disease Average Price of Key Manufacturers in 2015
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 3 Manufacturers
Figure Nonalcoholic Fatty Liver Disease Market Share of Top 5 Manufacturers
Table United States Nonalcoholic Fatty Liver Disease Sales by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Share by Type (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Market Share by Type in 2015
Table United States Nonalcoholic Fatty Liver Disease Revenue and Market Share by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nonalcoholic Fatty Liver Disease by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Price by Type (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Type (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Sales by Application (2011-2016)
Table United States Nonalcoholic Fatty Liver Disease Sales Market Share by Application (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Market Share by Application in 2015
Table United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2011-2016)
Figure United States Nonalcoholic Fatty Liver Disease Sales Growth Rate by Application (2011-2016)
Table Conatus Pharmaceuticals Basic Information List
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Daewoong Pharmaceutical Basic Information List
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daewoong Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Galmed International Basic Information List
Table Galmed International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Galmed International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Kyorin Pharmaceutical Basic Information List
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Metabolic Solutions Development Basic Information List
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Novartis AG Basic Information List
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Phenex Pharmaceuticals Basic Information List
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Raptor Pharmaceuticals Basic Information List
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table TCM Biotech International Basic Information List
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Tobira Therapeutics Basic Information List
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales, Revenue, Price and Gross Margin (2011-2016)
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nonalcoholic Fatty Liver Disease
Figure Manufacturing Process Analysis of Nonalcoholic Fatty Liver Disease
Figure Nonalcoholic Fatty Liver Disease Industrial Chain Analysis
Table Raw Materials Sources of Nonalcoholic Fatty Liver Disease Major Manufacturers in 2015
Table Major Buyers of Nonalcoholic Fatty Liver Disease
Table Distributors/Traders List
Figure United States Nonalcoholic Fatty Liver Disease Production and Growth Rate Forecast (2016-2021)
Figure United States Nonalcoholic Fatty Liver Disease Revenue and Growth Rate Forecast (2016-2021)
Table United States Nonalcoholic Fatty Liver Disease Production Forecast by Type (2016-2021)
Table United States Nonalcoholic Fatty Liver Disease Consumption Forecast by Application (2016-2021)